Alagille syndrome, which comprises complex cardiac defects and vascular anomalies. 5 However, little is known about the function of Jagged1 in adult neoangiogenesis.
Dll4 is predominantly expressed in the endothelium of capillaries and arteries, 6 whereas Jagged1 is expressed in both endothelial and vascular smooth muscle cells (vSMCs). 7 During developmental angiogenesis in the postnatal mouse retina, Dll4 is detected in endothelial tip cells at the distal end of sprouting vessels. 8 In contrast, Jagged1 is found in stalk cells at the sprout base. 9 A recent study has suggested that Dll4 and Jagged1 have opposite effects in mouse retinal vascular development. In this setting, Jagged1 acts as a positive regulator of sprouting and tip cell formation because of its ability to antagonize Dll4/Notch signaling, which acts as a negative regulator of these processes. 9 Previous work has also shown that endothelial Jagged1 is indispensable for the development of neighboring vascular smooth muscle, 10 which has been attributed to the induction of mural cell differentiation through Notch3 11 and RBP-Jkappa 12 activation. Despite considerable progress in understanding vascular morphogenesis during development, few studies have targeted in vivo angiogenesis in adult physiological settings. In mammals, physiological angiogenesis occurs mainly during tissue regeneration, such as in healing wounds, and in the female reproductive cycle. In particular, the wound healing assay constitutes a fast, easy, and reliable in vivo model of physiological angiogenesis for studying the molecular mechanisms involved in the formation and remodeling of vascular structures. 13 During regeneration, the vascular network at the wound edges expands through sprouting into the granulation tissue, which has increased oxygen and nutrient demand. Vascular endothelial growth factor (VEGF) is the main proangiogenic signal controlling this process. 14 Through the analysis of wound healing kinetics, vessel morphology, and gene expression in endothelial Jag1 or Dll4 mutants treated with ligand-specific antagonists, we provide the first evidence for an important proangiogenic role of endothelial Jagged1 in adult regenerative angiogenesis. Moreover, we present evidence supporting a synergistic effect of both ligands on mural cell recruitment and propose a new mechanism by which Dll4/Notch1 signaling promotes the recruitment of perivascular cells through the upregulation of Jag1 and Notch4 activation in endothelial cells (ECs).
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Endothelial Jagged1 Accelerates Wound Healing by Promoting Angiogenesis and Vessel Maturation
To better characterize the role of Jagged1/Notch signaling during adult physiological angiogenesis, wound healing kinetics were analyzed in endothelial-specific Jag1 gain-of-function and loss-of-function mutant mice.
EC-specific Jag1 overexpression (endothelial-specific Jag1 gain-of-function or conditional overexpression [eJag1OE]) led to significantly accelerated wound healing from day 2 of recovery onward relative to control animals. Accordingly, closing of eJag1OE wounds occurred 2 days faster on average ( Figure 1A ). In contrast, loss of endothelial Jag1 (endothelial-specific Jag1 loss-of-function or conditional knockout [eJag1cKO]) led to significantly delayed healing from day 2 of recovery with an average 2-day delay in the healing process ( Figure 2A ).
To address whether the altered wound closure kinetics observed in these EC-specific mutants was indeed associated with altered vessel growth, the vascular morphology of the samples collected at end point (day 7 of recovery) was examined. Blood vessel endothelium in the wounded area was visualized by immunostaining against platelet endothelial cell adhesion molecule-1 (PECAM-1), whereas α-smooth muscle actin (SMA) and platelet-derived growth factor-β (Pdgfr-β) were used to reveal perivascular cell and pericyte coverage, Figure 1C , the newly formed vasculature in eJag1OE mutants displayed highly branched networks and exhibited a greater maturation state, as indicated by the abundance of both perivascular cells and pericytes present. The opposite was seen in eJag1cKO mutant wounds, which showed a significant decrease in vascular density ( Figure 2B-2D ) as well as in the number of perivascular cells ( Figure 2B , 2C, and 2E) and pericyte coverage ( Figure IC and ID in the online-only Data Supplement). At high magnification, the vasculature of eJag1cKO wounds was sparse and with few SMCs ( Figure 2C ) and pericytes attached ( Figure IC and ID in the online-only Data Supplement).
We also evaluated wound vessel functionality by analyzing biotinylated lectin perfusion and Evans' blue dye vascular leakage ( Figures 1F, 1H , 2F, and 2H). As shown in Figure 1F and 1G, overexpression of Jag1 in the endothelium was associated with an increase in the amount of perfused, lectin-containing vessels. At the same time, Evans' blue extravasation was significantly reduced in comparison with controls ( Figure 1H and 1I) , suggesting an overall improvement in the functionality of newly formed vessels. Conversely, endothelial Jag1 loss of function led to a significant decrease in vascular perfusion (Figure 2F and 2G) and to an increase in extravasation per vessel area ( Figure 2H and 2I) . Taken together, endothelial Jag1 overexpression led to the formation of a dense, . Overexpression of Jag1 led to an increase in the healing rate of dermic wounds, with an average 2-day advance in comparison with controls (as demonstrated by the orange line). B, Immunostaining images (×10 amplification) of samples collected at day 7, marked for platelet endothelial cell adhesion molecule-1 (PECAM-1) (green) and smooth muscle actin (SMA) (red), to evaluate vascular density and vascular smooth muscle cell coverage, respectively. Continuous white line marks the base of epidermis and the space between dashed lines marks the angiogenic fronts. C, High-magnification (×40 amplification) confocal imaging showing in detail the vascular phenotype of eJag1OE mutants, consisting of an increased number of vessels, as seen by PECAM-1 + signal, and increased vessel coverage by SMA + cells, compared with the controls. D, Percentage of vascular density (relative to control=100%) is increased in endothelial Jag1 overexpression mutants, as shown by PECAM-1 labeling. E, Percentage of vascular smooth muscle coverage, showing increased levels of SMA on eJag1OE mutant vasculature, relative to controls. F, Lectin (red) and PECAM-1 (green) immunostaining (×20 amplification) of samples collected at end point, to evaluate the colocalization of both signals, indicative of vessel perfusion. G, Percentage of perfusion area in the total vascular area (given by vascular density measurements) showing increased lectin labeling in endothelial Jag1 overexpression mutants. H, Evans' blue (red) and PECAM-1 (green) confocal immunostaining images (×20 amplification) showing the extravasation areas. I, Percentage of vascular extravasation area in the total vascular area showing reduced leakage, or Evans' blue staining, in the eJag1OE mutant vasculature, relative to controls. 4′,6-Diamidino-2-phenylindole (DAPI; blue) stains nuclei. Results are representative of 2 independent experiments, each with n=4 mice per group. Error bars represent SEM; *P<0.05; **P<0.01; and ***P<0.001. fluorescence-activated cell sorting sorted from wound samples collected at the experimental end point (ie, day 7 of recovery; Figure 3A ). In ECs ( Figure 3B ), Jag1 transcript levels were largely increased (3-fold) in eJag1OE mutant samples and significantly reduced in eJag1cKO animals. In contrast, Dll4 was upregulated in eJag1cKO and downregulated in eJag1OE mutants. Transcript levels for Pdgfb (encoding PDGF-B, the endothelial ligand for PDGFRβ) and Tek (encoding the Tie2 receptor tyrosine kinase), which control the recruitment of perivascular cells and vascular permeability, respectively, 15, 16 were downregulated in eJag1cKO mutants and increased in gain-of-function mutants. The same was the case for the mRNAs encoding VEGF receptor-2 (Vegfr2/ Kdr/Flk1) and 3 (Vegfr3/Flt4) ( Figure 3B ).
About known Notch effectors, we observed that Hey2 and Hes1 transcript levels were augmented in eJag1cKO samples and downregulated in eJag1OE. However, Hey1 and Hes2 were upregulated in eJag1OE and reduced in eJag1cKO wound ECs. Nrarp, a gene that is known to be rapidly upregulated in response to Dll4/Notch signaling, was strongly upregulated in the absence of endothelial Jag1 and downregulated in the Jag1 gain-of-function samples. The Notch receptor gene Notch 4 was upregulated in eJag1OE wounds, whereas in eJag1cKO only Notch1 was upregulated, and Notch4 was robustly and significantly reduced.
Furthermore, mural cell-specific transcription analysis ( Figure 3C ) revealed a downregulation of PdgfrB (encoding PDGFRβ), Ang1 (perivascular ligand for Tie2 receptor), Notch3 receptor, and HeyL (perivascular cell notch effector) in eJag1cKO and an upregulation in eJag1OE mutants wounds. To obtain additional validation on the specific modulation of Notch effectors by endothelial Jagged1, immunofluorescence was performed for the main endothelial Notch effectors Hey1 These results indicate that Jag1 modulation in the endothelium is able to ellicit changes in the expression profiles of Notch receptors and effectors as well as in genes controlling angiogenesis and the recruitment of mural cells.
Blocking Dll4 in Endothelial Jag1 Knockout Mice Rescues Angiogenesis but Not Mural Cell Coverage
The results obtained in the wound healing assays performed in Jag1 mutants together with previous results from our laboratory describing a role for Dll4 in wound healing angiogenesis 3 gave rise to the hypothesis that the loss of endothelial Jag1 enables more robust Dll4/Notch signaling. In the absence of Jagged1, more Notch receptors would be left available to be activated by Dll4, which has a strong antiangiogenic function and might thereby cause a delay in wound healing. 3 Conversely, in eJag1OE animals, the proangiogenic phenotype might be associated with decreased Dll4/Notch signaling. We therefore wanted to determine whether the eJag1cKO phenotype was mainly because of upregulation of Dll4/Notch signaling. We performed wound healing assays in eJag1cKO mutant mice treated with anti-Dll4 blocking antibody (antiDll4). As shown in Figure 5 , anti-Dll4 administration increased the angiogenic growth of the endothelium, in both control (control+anti-Dll4) and eJag1cKO (eJag1cKO+anti-Dll4) mouse groups but led to significantly delayed wound With regard to ECs and mural cell-specific gene expression ( Figure III in the online-only Data Supplement), we observed downregulation of Notch-related genes both in extra control mouse group (control+anti-Dll4) as in eJag1cKO (eJag1cKO+anti-Dll4) mouse groups treated with anti-Dll4 antibody. Administration of anti-Dll4 to eJag1cKO mutants reverted the upregulation of Dll4, Notch1, Hey2, Hes1, and Nrarp observed previously in these mutant mice ( Figure IIIA in the online-only Data Supplement). Also, as expected, blockade of Dll4 alone (control+anti-Dll4) led to a downregulation of Jag1 transcript levels, confirming the previously obtained results indicating that Jag1 expression was downstream of Dll4/Notch signaling. 3 In addition, we observed a downregulation response in the transcription of mural cell-specific genes (Figure IIIB in the online-only Data Supplement) in all analyzed mouse groups.
In summary, these observations indicate that Jag1 and Dll4 have opposing effects on regenerative angiogenesis in the adult organism. However, the data suggest a synergistic function of the 2 ligands in vessel maturation and perivascular cell recruitment to nascent vessels.
Vascular Maturation in Endothelial-Specific Dll4 Gain-of-Function or Conditional Overexpression Mice Is Impaired by Jagged1 Blockade
The results described to date show that Dll4 inhibition in eJag1cKO mice further diminishes the mural cell coverage of the vascular plexus formed during wound healing. Previous work done by our group has established that endothelialspecific overexpression of Dll4 (endothelial-specific Dll4 gain-of-function or conditional overexpression [eDll4OE]) induces an increase in vSMC coverage of the vasculature. 3 To better understand the interaction between Dll4 and Jagged1 signaling in the vessel maturation process, we treated eDll4OE mutants with an anti-Jagged1 blocking antibody and analyzed the effect of this inhibition on wound healing. In accordance with our previous study, 3 Dll4 overexpression in the endothelium led to a significant delay in wound closure relative to controls ( Figure 6A ). This reduction in the healing ability was phenocopied by Jagged1 inhibition in control animals (control+anti-Jag1), which argued further for opposing roles of Dll4 and Jag1. In addition, treatment of eDll4OE mutants with anti-Jagged1 antibody severely impaired tissue regeneration suggesting that inhibition of Jagged1 further , and eJag1cKO treated with anti-Dll4 antibody (eJag1cKO+A-Dll4). B, Confocal immunostaining images (×40 amplification) marked for platelet endothelial cell adhesion molecule-1 (PECAM-1) (green) and smooth muscle actin (SMA) (red), to evaluate vascular density and vascular smooth muscle cell (vSMC) of samples collected at day 7. C, Percentage of vascular density (relative to control=100%) showing that the administration of anti-Dll4 either to control (ctrl+A-Dll4) or to eJag1cKO (eJag1cKO+A-Dll4) mice led to an increase in vascular density. D, Percentage of vSMC coverage demonstrating that anti-Dll4 administration decreased the SMA + perivascular coverage of control (ctrl+A-Dll4) mice and caused an even more pronounced decrease in eJag1cKO mutants treated (eJag1cKO+A-Dll4). 4′,6-Diamidino-2-phenylindole (DAPI; blue) stains nuclei. Results are representative of 2 independent experiments, with n=5 in the control group, n=5 (eJag1cKO), and n=4 in each anti-Dll4-treated group. Error bars represent SEM; *P<0.05; **P<0.01; and ***P<0.001.
by guest on April 13, 2017 http://atvb.ahajournals.org/ Downloaded from Figure 6 . Endothelial-specific Dll4 overexpression combined with administration of anti-Jagged1 antibody in wound healing assay. A, Progression of average wound size relative to day 0 in 4 mouse groups: control, control treated with anti-Jagged1 antibody (control+A-Jag1), endothelial-specific Dll4 overexpression (eDll4OE), and eDll4OE treated with anti-Jagged1 antibody (eDll4OE+A-Jag1). B, Immunostaining images (×20 amplification) for platelet endothelial cell adhesion molecule-1 (PECAM-1) (green) and smooth muscle actin (SMA) (red), used to evaluate vascular density and perivascular coverage of samples collected at day 7. Continuous white line marks the base of epidermis and dashed lines mark the angiogenic fronts. C, Confocal immunostaining images (×40 amplification) showing the perivascular phenotype in detail; control mice treated with anti-Jagged1 antibody have consistently less vessels, as seen by PECAM-1 + signal, and an almost complete absence of SMA staining associated with the vessel wall; note that eDll4OE mutant vessels seem to be enlarged because of the high number of SMA + cells associated with the vessel wall. In eDll4OE mutants treated with anti-Jagged1 antibody, wound vessels are thinner than in eDll4OE and control mice, with less SMA + perivascular cells. D, Percentage of vascular density (relative to control=100%) showing decreased PECAM-1 staining in all groups compared with the controls. E, Percentage of vascular smooth muscle cell coverage, showing PECAM-1/SMA + signal is highly increased in eDll4OE mutants; this phenotype is strongly reversed by blocking Jagged1 signaling, both in control and in mutant animals. F, High-magnification (×40 amplification) confocal imaging of Jagged1 staining in the vessels of eDll4OE mutants, showing strong Jagged1 levels in vessels with higher SMA + coverage compared with the control. 4′,6-Diamidino-2-phenylindole (DAPI; blue) stains nuclei. Results are representative of 1 experiment, with n=7 in the control and eDll4OE groups and n=8 in the control and eDll4OE treated with anti-Jagged1 antibody groups. Error bars represent SEM; *P<0.05; **P<0.01; and ***P<0.001.
hampers growth and function of the dermal vasculature. No evident anti-Jag1-induced effects were observed during the experimental period in tissues other than the vasculature (data not shown).
Microscopical analysis of the vasculature at high magnification revealed that both Dll4 overexpression and Jagged1 inhibition were able to induce a significant decrease in the vascular density of the granulation tissue. This effect was most pronounced after Jagged1 inhibition in eDll4OE mutant mice ( Figure 6B-6D) , which suggested that Dll4 overexpression and Jagged1 blockade have additive antiangiogenic effects.
Moreover, eDll4OE mutant vasculature displayed a high ratio of coverage by SMA + cells ( Figure 6B and 6C) and pericytes ( Figure IVA and IVB in the online-only Data Supplement), despite the reduced vascular density observed. Conversely, Jagged1 antibody inhibition significantly reduced the proportion of vessels covered by vSMCs ( Figure 6E ) and pericytes ( Figure IVA and IVB in the online-only Data Supplement) in both controls and eDll4OE animals. These results argue that Jagged1-mediated signaling is indispensable for the proper mural cell recruitment and sustainment of SMC and pericyte coverage during adult physiological angiogenesis. Moreover, the observed loss of maturation may be responsible for the diminished vascular perfusion and increased extravasation in animals treated with Jagged1 blocking antibody ( Figure IVC In line with previous findings suggesting that Jag1 expression is positively regulated by Dll4 3 and with the observed Jagged1 upregulation ( Figure VA in the online-only Data Supplement), immunostaining for Jagged1 in eDll4OE mutant vasculature showed much greater intensity in comparison with controls ( Figure 6F ). This suggests that Jagged1 is a downstream effector of Dll4/Notch signaling in the endothelium.
Endothelial Jagged1 Activates Notch3 Receptor in Perivascular Cells and Notch4 in ECs
It has been proposed that Jagged1 signals through Notch3 in perivascular cells. 11 To confirm this, we immunostained the intracellular domain of Notch3 (N3ICD) in the wound samples from mutants that presented increased recruitment of mural cells: eJag1OE and eDll4OE. Endothelial Jag1 overexpression mutants presented increased perivascular N3ICD positive staining compared with the respective controls ( Figure VIA and VIB in the online-only Data Supplement), measured as double positive staining for SMA and N3ICD. Conversely, administration of anti-Jagged1 to control animals (control+anti-Jag1) led to decreased N3ICD positive staining, whereas eDll4OE mutants presented increased staining ( Figure VIC and VID in the online-only Data Supplement). Predictably, blocking Jagged1 in eDll4OE (eDll4OE+anti-Jag1) reversed the increased staining observed in the mutants, bringing N3ICD to levels comparable with control animals ( Figure VIC and VID in the online-only Data Supplement).
Despite the evidence for the ability of Jagged1 to activate perivascular Notch3, the endothelial Notch receptor(s) for Jagged1 remained unknown. Both Notch1 and Notch4 are prominently expressed in ECs, 7 therefore to better understand the downstream signaling elicited by endothelial Jagged1, immunofluorescence staining for the intracellular domains of Notch1 (N1ICD) and Notch4 (N4ICD) was performed in wound samples from eJag1 mutants (Figure 7) . Jag1 overexpression led to a significant decrease in the amount of PECAM-1 + vessels showing activation of Notch1 (double positive N1ICD/PECAM-1 vessels; Figure 7A and 7B). The opposite effect was seen in eJag1cKO mutants where the proportion of N1ICD + vessels was increased relative to controls ( Figure 7E and 7F) . Surprisingly, levels of activated Notch4 (N4ICD) were increased in eJag1OE mutants ( Figure 7C and 7D), whereas conditional deletion of Jag1 in the endothelium was associated with a decrease in the colocalization of N4ICD and PECAM-1 staining ( Figure 7G and 7H) .
We also quantified endothelial N1ICD in eJag1cKO animals treated with anti-Dll4 and N4ICD in eDll4OE mutants treated with anti-Jag1 ( Figure VII in the online-only Data Supplement). Anti-Dll4 administration reversed the increase of ECs with cleaved (active) Notch1 in eJag1cKO samples ( Figure VIIA and VIIB in the online-only Data Supplement). Likewise, anti-Jag1 administration significantly reduced the N4ICD-positive area in the eDll4OE endothelium ( Figure VIIC and VIID in the online-only Data Supplement). Moreover, anti-Dll4 administered either to control (control+anti-Dll4) or eJag1cKO (eJag1cKO+anti-Dll4) mouse groups also led to reduced levels of active endothelial Notch4 ( Figure VIIIA and VIIIB in the online-only Data Supplement). In the same manner, administration of anti-Jag1 either to control (control+anti-Jag1) or eDll4OE (eDll4OE+anti-Jag1) mouse groups also showed a sustained increase in active endothelial Notch1 ( Figure VIIIC and VIIID in the online-only Data Supplement). These results argue that Jagged1 is able to trigger Notch4 receptor activation in ECs, whereas the receptor Notch1 seems to be preferentially activated by Dll4.
Administration of a Notch4 Agonist to Wild-Type Mice Accelerates Wound Healing by Promoting Vessel Maturation Without Affecting Angiogenic Growth
To provide independent evidence of the role of Notch4 in the vascular response and to better ascertain whether indeed endothelial Notch4 also contributes to the vascular maturation process, we administered a Notch4 agonistic antibody to wild-type (WT) mice and evaluated the healing response. Administration of a Notch4 agonist to WT mice (WT+N4 Agonist) led to significantly accelerated wound healing from day 2 of recovery ( Figure IXA Transcription analysis further supported our previous results, with the same set of genes that were upregulated in eJag1OE also being upregulated in WT + N4 agonist mice ( Figure XIA in the online-only Data Supplement). This group of genes included all the analyzed genes involved in recruitment of perivascular cells, such as Pdgfb, Pdgfr-β, Tek, and Ang-1. It also included Jag1, Notch4, Notch3, Hey1, and HeyL. Contrastingly, Dll4, Notch1, and Hey2 transcription levels showed no significant changes in the WT + N4 agonist group.
Accordingly to the transcription analysis, Notch4 agonist injected animals showed increased endothelial Hey1 positive area ( Figure XIB and XIC in the online-only Data Supplement), whereas no significant differences were observed on Hey2 staining ( Figure XID and XIE in the onlineonly Data Supplement).
These results reinforce the evidence for the role of endothelial Jagged1/Notch4 signaling in the process of vascular maturation.
Discussion
This article addresses the role of Jagged1/Notch signaling and its relation to the other major Notch ligand, Dll4, during angiogenic processes related to skin wound healing. In particular, our results establish that the proangiogenic role of Jag1 observed in developmental processes 9 is also relevant for regenerative angiogenesis in the adult. We found that endothelial Jag1 overexpression improved the healing rate of dermal wounds and was associated with an increase in the density, maturation, and functionality of the newly formed vasculature, whereas endothelial-specific Jag1 knockout had the opposite effect. VEGF receptors were upregulated in eJag1OE mutants and downregulated in eJag1cKO samples. This finding is consistent with previously published work 9 showing that Jagged1 can promote VEGF signaling by upregulating the levels of Vegfr3 and Vegfr2.
Given our previous studies with endothelial-specific Dll4 mutants, 3 the eJag1cKO loss-of-function endothelial phenotype is similar to that observed in eDll4OE mutants, whereas the eJag1OE phenotype corresponds to that observed in eDll4cKO mutants. Dll4 blockade with an anti-Dll4 antibody led to delayed wound healing, in accordance with our previous study where we showed the same wound healing kinetics using either endothelial-specific Dll4 loss-of-function mutant mice or administration of a soluble Dll4-Fc fusion protein. 3 Administration of anti-Dll4 to eJag1cKO mutants led to a further delay in wound healing and significantly increased vascular density, demonstrating the opposing roles of the 2 Notch ligands in the endothelium, Dll4 antiangiogenic and Jagged1 proangiogenic.
In addition, our new data show that Jagged1 and Dll4 have also overlapping functional roles in the vasculature, as both ligands contributed to increased vSMC and pericyte coverage and reduced vascular leakage during wound healing angiogenesis. We propose that Jagged1/Notch signaling might be directly responsible for maturation processes in a newly formed vascular plexus acting downstream of Dll4. This is supported by the observation that the perivascular phenotype observed in eDll4OE mutants is linked to the downstream upregulation of Jag1, which was visible both at the transcript level and at the protein level, as shown in Figure 5F . Accordingly, treatment of eDll4OE mutants with anti-Jagged1 antibody led to decreased recruitment of mural support cells. In line with our observations, High et al 10 have shown that endothelial-specific Jag1 knockout mutant embryos have striking deficits in vascular smooth muscle, whereas endothelial Notch1 activation and arterial-venous differentiation seemed normal. They also showed that endothelial Jag1 mutant embryos are phenotypically distinct from embryos in which Notch signaling is inhibited in the endothelium. Therefore, the primary role of endothelial Jagged1 may be to potentiate the development and differentiation of neighboring vSMCs. Thus, Jagged1 not only counteracts Dll4/Notch in the endothelium but also generates a balance between angiogenic growth and maturation processes. Our observations also suggest that endothelial Jagged1 negatively regulates the transcription and activation of Notch1, whereas it positively controls the transcription and activation of Notch4. Our colocalization analysis suggests that Jagged1 might be unable to trigger substantial Notch1 activation. Accordingly, a recent study 17 demonstrated that in vitro cultivation of ECs in high glucose conditions causes increased angiogenesis because of Jagged1 overexpression and inhibition of Notch1. Conversely, eJag1cKO mutants, where the transcript levels of Dll4 were upregulated, showed a significant increase in N1ICD-positive endothelium. This increase was reverted by blocking Dll4 with anti-Dll4 antibody. In addition, antibody blocking of Jagged1 failed to revert the increased active endothelial Notch1 observed in eDll4OE mouse mutants, suggesting that Notch1 is mainly activated by Dll4. In fact, the embryonic lethal phenotype observed in Notch1 −/− mice is similar to that of Dll4 −/− embryos. 2, 18, 19 From the analysis of endothelial N4ICD in the eJag1 mutants, where endothelial N4ICD positive area is higher in eJag1OE mutants and lower in eJag1cKO, it seems that Jagged1 is able to activate Notch4 in the endothelium, as previously suggested. 20, 21 Moreover, the vasculature of eDll4OE mutants, where Jag1 expression is high, has increased numbers of N4ICD positive ECs, which are not observed when Jagged1 signaling is blocked. Additionally, blocking of Dll4 in either control (control+anti-Dll4) or eJag1cKO (eJag1cKO+anti-Dll4) mice also led to decreased endothelial activation of Notch4, which was expected because of the downstream downregulation of Jag1 transcript levels that is observed in these mice.
Furthermore, we have also showed that administering a Notch4 agonistic antibody to WT mice accelerated the healing response, similar to what was observed in eJag1OE mutants. Vasculature analysis of the injected mice showed no alteration in vascular density but sustained increase in vSMC and pericyte coverage, suggesting this receptor to be mainly involved in the vascular maturation response. Therefore, these results support the hypothesis that the proangiogenic phenotype observed in eJag1OE mutants can be a consequence of, first, inhibiting Notch1 activation, resulting in increased angiogenic growth, and second, activating Notch4, which in turns drives vascular maturation. In addition, the immunofluorescence and transcription analysis of both eJag1 mutants and Notch4 agonist-administered mice suggest that activation of Notch4 by endothelial Jagged1 results in the transcription of specific target genes, namely Hey1. 22 Conversely, the other major Notch effector, Hey2, was upregulated in eJag1cKO and in eDll4OE mutants, which in both cases is likely to be a consequence of increased Dll4/Notch1 signaling. 8 activates Notch1 in adjacent cells leading to the transcription of specific Notch effectors (namely Hey2) and upregulating endothelial Jag1 transcription and expression. Moreover, Jagged1 is responsible for antagonizing Dll4 ability to bind to and activate Notch1 in tip cells, creating a negative feedback loop in the regulation of endothelial branching. 9 Furthermore, endothelial Jagged1 positively regulates vascular maturation by 2 possible mechanisms: by activating endothelial Notch4 leading to the transcription of specific Notch effectors (namely Hey1); and by activating Notch3 in vascular smooth muscle cells.
Evidence for a role of Notch and, more specifically, Jagged1 in endothelial contact-dependent recruitment of smooth muscle progenitor cells in vivo was provided by the deletion of Notch signaling activity in neural crest-derived smooth muscle progenitors 23 and in experiments where Jag1 was deleted specifically in ECs. 10 Thus, endothelial Jagged1 is also able to bind Notch3 on neural crest-derived smooth muscle progenitors, which leads to the lateral induction of Jagged1/Notch signaling and directs the expression of HeyL and other signals laterally into the growing circumferential wall, as suggested by Liu et al. 11 Here, we show the ability of endothelial Jagged1 to activate perivascular Notch3. We have detected increased levels of N3ICD in SMCs in both eJag1OE and eDll4OE mutants. Moreover, administration of anti-Jagged1 to eDll4OE mutants brought N3ICD levels back to control levels. Most importantly, these results suggest that Jagged1/ Notch4 endothelial signaling can also contribute to the assembly of a SMC layer by regulating the transcription of key components of pathways associated with vascular maturation and perivascular cell recruitment. In particular, these data point at the ANG-1/TIE-2 and PDGF-B/PDGFRβ pathways as possible targets of Jagged1/Notch signaling, as has been previously suggested. 24 Nonetheless, further studies are required to distinguish the roles of Jagged1/Notch4 and Jagged1/Notch3 signaling in the process of vascular maturation.
In our proposed model (Figure 8 ), endothelial Jagged1 acts downstream of Dll4/Notch1 to produce 2 distinct effects. First, Jagged1 is responsible for antagonizing Dll4 ability to bind to and activate Notch1 in tip cells, creating a negative feedback loop in the regulation of endothelial branching, as described in the developing retina. 9 Second, by activating Notch4 in ECs and Notch3 in vSMCs, Jagged1 positively regulates vascular maturation downstream of Dll4/Notch1 signaling.
In conclusion, this study is the first to demonstrate the proangiogenic role of endothelial Jagged1 in adult physiological angiogenesis and the synergistic roles of endothelial Jagged1 and Dll4 on vascular maturation. Also, it is the first study to reveal Jagged1 as a potential therapeutic target in wound healing. We have previously presented results showing that low dosage inhibition of Dll4 function could produce a proangiogenic phenotype, while maintaining an intact network of functional blood vessels. 3 This approach might enable faster wound healing and regenerative processes. The current results establish that increased endothelial expression of Jagged1 has a more profound proangiogenic effect that promotes healing processes by increasing vessel density but also improved maturation of the newly formed wound vasculature. This goes way beyond what Dll4 targeting/inhibition alone can achieve. Activation of Jagged1 expression may well prove potentially useful in situations where vascular function is a limiting factor in patient recovery, like in ischemia or wound healing. In the case of diabetic retinopathy, increased Jagged1 signaling could be used to stabilize and promote the maturation of nascent blood vessels, which could help to reduce edema and hypoxia of retinal tissues in this condition. However, blocking Jagged1 is likely to be useful in cases where it is desirable to limit vascular growth such as in antiangiogenic cancer therapy.
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Supplemental Figure -) sorted population relative gene transcription. Gene transcript levels were normalized to PECAM-1 mRNA levels, and the house-keeping gene β-actin was used as endogenous control. Green bars represent the relative gene expression of the samples collected from control mice treated with Anti-Jag1 (ctrl +A-Jag1), the purple bars represent the relative gene expression levels from eDll4OE mutants and the blue bars represent the relative gene expression from eDll4OE mutants treated with Anti-Jag1 (eDll4OE + AJag1) relative to the control group. Error bars represent SEM; * represents p<0.05; ** represents p<0.01; *** represents p<0.001. A) and C) Confocal immunostaining images (40x amplification) of PECAM (green), SMA (red) and N3ICD (blue) in eJag1OE mutants and Anti-Jag1-treated eDll4OE mutants, respectively; co-staining (pink colour) labels the localization of cleaved Notch3 in perivascular cells (white arrows). B) Percentage of perivascular N3ICD-positive area (relative to control=100%) is increased in eJag1OE animals relative to controls. D) Percentage of perivascular N3ICD-positive area (relative to control-100%); N3ICD is decreased in Ctrl+A-Jag1 while highly increased in eDll4OE mutants. Error bars represent SEM; * represents p<0.05; ** represents p<0.01; *** represents p<0.001. A) Confocal immunostaining images (40x amplification) of four mouse groups: controls (Control-Jag1 lox/lox Cre-), control treated with anti-Dll4 antibody (Control+A-Dll4), Jag1 loss-of-function mutants (eJag1cKO-Jag1 lox/lox Cre+), and eJag1cKO treated with anti-Dll4 antibody (eJag1cKO+A-Dll4); PECAM-1 (green) and N1ICD (red) co-staining labels the localization of cleaved Notch1 in endothelial cells (white arrows). B) Percentage of endothelial N1ICD-positive area (relative to control=100%); Control mice group administered with anti-Dll4 has decreased N1ICD in endothelial cells; untreated eJag1cKO endothelial cells have increased N1ICD; this phenotype is reversed in mutants treated with Anti-Dll4. C) Confocal immunostaining images (40x amplification) of wound tissue sections from four different groups of animals: controls, control animals treated with anti-Jagged1 (Control+A-Jag1), eDll4OE mutants (eDll4OE) and eDll4OE mutants treated with anti-Jagged1 (eDll4OE+A-Jag1); the co-localization of PECAM (green) and N4ICD (red) indicates the presence of N4ICD in endothelial cells ECs (white arrows). D) Percentage of endothelial N4ICD-positive area (relative to control-100%); N4ICD is highly increased in eDll4OE endothelial cells; this phenotype is strongly reversed by blocking Jagged1 signaling, both in Control and in mutant animals. DAPI (blue) stains nuclei. Error bars represent SEM; * represents p<0.05; ** represents p<0.01; *** represents p<0.001.
10, 20X and 40X/0.5 NA dry objectives (Leica, Heidelberg, Germany), captured using Photometrics CoolSNAP HQ, (Photometrics, Friedland, Denmark), and processed with Metamorph 4.6-5 (Molecular Devices, Sunnyvale, CA). The high-magnification confocal images were obtained using a Carl Zeiss LSM 780 confocal microscope with Zeiss 40X (LD C-Apo) NA 1.10 water immersion objective, and captured using ZEN 2012 Black edition software (Carl Zeiss, Jena, Germany). Morphometric analyses were performed using the NIH ImageJ 1.37v program (NIH, Bethesda, MA, USA).
For immunostaining quantification a defined window (26,5 cm wide per 17,6 cm height) was used and applied to select an area from the wound front in each image. In sequenced images the area selected at the wound front was moved along the vascular plexus in order to be able to collect and analyze windows from all areas of the wound edges. Pixel intensity measurements (determined by the percentage of white pixels per field after transforming the RGB images into binary files) were then applied to each selected window using Imaje J. In the case of co-localization quantification (SMA, Pdgfr-β, Hey1/2, Lectin and NICDs stainings) pixel intensity measurements were applied but to intact RGB images in order to quantify overlaying signals from two different channels.
Quantitative transcriptional analysis
Wound samples were collected at the endpoint of each experiment and prepared for FACS sorting. ECs and Mural cells were sorted directly into the lysis buffer of the RNeasy Micro Kit (Qiagen). Total RNA was isolated according to manufacturer's protocol. A total of 100 ng RNA per reaction was used to generate cDNA with the SuperScript III First Strand Synthesis Supermix Q RT-PCR Kit (Invitrogen, CA). Relative quantification real-time PCR analysis was performed as described 3 using Sybergreen Fastmix ROX dye (Qiagen). Primer pair sequences are available on request. The housekeeping gene β-actin was used as endogenous control. , 2 wound samples were collected per each animal and finely dissected into small pieces (2-4 mm). Then, the samples were digested with collagenase (Sigma) incubation at 37ºC, with agitation, for 4h30 min. DNAse I (Sigma) was added during digestion to eliminate DNA residues. After washing, digested cells were then subjected to immunostaining with anti-mouse ter-119 PE-Cy7, anti-mouse cd45 PE-Cy7 (Affymetrix, eBioscience), anti-mouse cd31 FITC and anti-mouse cd146 PE (BD Pharmingen). After washing, cells were sorted in FACS Aria III cytometer and analyzed using BD FlowJo software (Version 10.0, BD Bioscience).
Flow cytometry
For demarcating and sorting ECs and mural cells, first standard quadrant gates were set, subsequently to differentiate cd31 + (>10 3 log FITC fluorescence) and cd146 + (>10 log PE fluorescence) cells from the Lineage negative population (≤10 2 log PE-Cy7 fluorescence).
Statistical analysis
Data processing was carried out using the Statistical Package for the Social Sciences software, version 17.0 (SPSS v. 17.0; Chicago, IL). Statistical analyses were performed using Mann-Whitney-Wilcoxon test and Student's t-test. All results are presented as mean ± SEM. P-values < 0.05, <0.01 and <0.001 were considered significant (indicated in the figures with *) and highly significant (indicated with ** and ***), respectively.
